Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127735111 | 12773511 | 1 | I | 20160909 | 20160922 | 20160922 | EXP | US-AMNEAL PHARMACEUTICALS-2016AMN00586 | AMNEAL | 63.00 | YR | M | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127735111 | 12773511 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | UNK | Y | 75927 | ||||||||||
127735111 | 12773511 | 2 | C | BENAZEPRIL | BENAZEPRIL HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
127735111 | 12773511 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | Y | 0 | ||||||||||
127735111 | 12773511 | 4 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127735111 | 12773511 | 1 | Osteoarthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127735111 | 12773511 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127735111 | 12773511 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127735111 | 12773511 | 1 | 20130220 | 20140731 | 0 | |
127735111 | 12773511 | 2 | 20080101 | 0 | ||
127735111 | 12773511 | 3 | 20130220 | 20140731 | 0 | |
127735111 | 12773511 | 4 | 20080101 | 0 |